Permanent Injunction Ends Topamax Patent Fight

Law360, New York (March 22, 2007, 12:00 AM EDT) -- A federal judge on Tuesday issued a final judgment in favor of Ortho-McNeil Pharmaceutical Inc. in the company’s patent infringement fight over a generic version of its blockbuster epilepsy drug.

After previously ruling that Mylan Laboratories Inc.’s generic version of Topamax infringed on Ortho-McNeil’s patent, Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey issued a permanent injunction against Mylan, effectively ending the longstanding dispute. The ruling also postponed the issuance of the generic drug until September 2008.

Additionally, Judge...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.